Follow
Clinical Trials
Clinical Trials: A clinical trial involves research participants. It follows a pre-defined plan or protocol to evaluate the effects of a medical or behavioral intervention on health outcomes. Clinical trials are done to determine whether new drugs or treatments are safe and effective. By taking part in clinical trials, participants not only play a more active role in their own health care, but they also can access experimental treatments and help others by contributing to medical research.
What's Popular in Clinical Trials
-
MAY 20, 2026eBooksFrom Insight to Impact: The Strategic Role of Biomarkers in Drug Discovery and Clinical Trials Every decision in drug de ...Sponsored By: Olink ProteomicsMAY 19, 2026Drug Discovery & DevelopmentNew research shows that it may be possible to repurpose asthma drug, montelukast, to treat various forms of aggressive c ...Written By: Annie LennonMAY 18, 2026Clinical & Molecular DXFor manufacturers, medical device companies, and laboratories that use the commercial diagnostic tests they produce, obt ...Sponsored By: Clinical and Laboratory Standards Institute (CLSI)MAY 17, 2026CancerOligometastatic cancer, a specific type of metastasis that occurs when cancer cells from a primary tumor travel within t ...Written By: Katie KokolusMAY 17, 2026Genetics & GenomicsResearchers have identified a portion of the human genome known as PTCHD1-AS on the X chromosome that does not code for ...Written By: Carmen Leitch
MAY 20, 2026
eBooks
From Insight to Impact: The Strategic Role of Biomarkers in Drug Discovery and Clinical Trials Every decision in drug de
...
Sponsored By:
Olink Proteomics
MAY 19, 2026
Drug Discovery & Development
New research shows that it may be possible to repurpose asthma drug, montelukast, to treat various forms of aggressive c
...
Written By:
Annie Lennon
MAY 18, 2026
Clinical & Molecular DX
For manufacturers, medical device companies, and laboratories that use the commercial diagnostic tests they produce, obt
...
Sponsored By:
Clinical and Laboratory Standards Institute (CLSI)
MAY 17, 2026
Cancer
Oligometastatic cancer, a specific type of metastasis that occurs when cancer cells from a primary tumor travel within t
...
Written By:
Katie Kokolus
MAY 17, 2026
Genetics & Genomics
Researchers have identified a portion of the human genome known as PTCHD1-AS on the X chromosome that does not code for
...
Written By:
Carmen Leitch
MAY 14, 2026
Immunology
Brain cancer or glioblastoma is an aggressive tumor that affects just four out of every 100,000 people in America. Scien
...
Written By:
Brian G. Morreale
MAY 05, 2026
Drug Discovery & Development
Low-dose minocycline, an antibiotic used to treat bacterial infections, has shown promise in treating panic attacks.
Written By:
Annie Lennon
APR 19, 2026
Cell & Molecular Biology
Researchers have found a natural molecule that seems to function like some of the new weight loss drugs, GLP-1 agonists
...
Written By:
Carmen Leitch
APR 17, 2026
Drug Discovery & Development
A new systematic review of 17 clinical trials found that drugs targeting amyloid beta proteins are likely to have no cli
...
Written By:
Annie Lennon
-
MAY 21, 2026 | 8:00 AMInvestigational Products (IP) present a distinctively high-risk environment for labeling. Unlike commercial pharmaceuticals, IP are often not mandated to adhere to standardized labeling or b...APR 30, 2026 | 7:30 AMAs lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and analytical strategies must evolve together. In this joint webinar...APR 23, 2026 | 10:00 AMCancer care has been transformed by comprehensive molecular profiling and targeted therapies—but with improvements in sample analysis technologies, the volume of information and burden...OCT 29, 2025 7:00 AM PTThis presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...OCT 23, 2025 | 10:00 AMCancer care has been transformed by comprehensive molecular profiling and targeted therapies—but with improvements in sample analysis technologies, the volume of information and burden...
MAY 21, 2026 | 8:00 AM
Investigational Products (IP) present a distinctively high-risk environment for labeling. Unlike commercial pharmaceuticals, IP are often not mandated to adhere to standardized labeling or b...
APR 30, 2026 | 7:30 AM
As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and analytical strategies must evolve together. In this joint webinar...
APR 23, 2026 | 10:00 AM
Cancer care has been transformed by comprehensive molecular profiling and targeted therapies—but with improvements in sample analysis technologies, the volume of information and burden...
OCT 29, 2025 7:00 AM PT
This presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...
OCT 23, 2025 | 10:00 AM
Cancer care has been transformed by comprehensive molecular profiling and targeted therapies—but with improvements in sample analysis technologies, the volume of information and burden...
JUN 17, 2025 | 8:00 AM
Biomarkers are no longer just exploratory tools-they're becoming strategic assets in drug development and clinical trials. Join a panel of industry thought leaders as they explore how biomar...
Speaker:
Dawn Waterworth
, Magnus Althage
, Jen-Chieh Chuang
, Ray Chen
Sponsored By: Olink Proteomics
JUN 11, 2025 | 8:00 AM
Advances in tissue-based technology in the past few years have created unprecedented opportunities to identify biomarkers of disease processes, especially within oncology by using multi-omic...
JUN 05, 2025 | 9:00 AM
Harmonizing immunophenotyping assay designs facilitates integrating findings across trials, enabling biomarker identification and validation, revealing cohort-specific features and drug mech...
On Demand
C.E. CREDITS
Precision oncology holds immense promise but presents a staggering computational and clinical challenge. Each tumor typically harbors 4 to 5 actionable driver alterations, chosen from millio...
Speaker:
Istvan Petak, MD, PhD
-
Be Part of the Global Proteomics Movement – Join Olink Proteomics World After the incredible success of Olink Proteomics World 2024 —which brought together over 20 global speaker...Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......Labroots and the Cell & Gene Therapy planning committee are pleased to announce Cell & Gene Therapy Virtual Event Series, taking place on October 14th, 2026. The Cell & Gene Ther...Labroots is excited to announce the 17th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 11th, 2026! This event will again bring togethe...Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Be Part of the Global Proteomics Movement – Join Olink Proteomics World After the incredible success of Olink Proteomics World 2024 —which brought together over 20 global speaker...
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......
Labroots and the Cell & Gene Therapy planning committee are pleased to announce Cell & Gene Therapy Virtual Event Series, taking place on October 14th, 2026. The Cell & Gene Ther...
Labroots is excited to announce the 17th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 11th, 2026! This event will again bring togethe...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Labroots is pleased to announce the 6 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 28th, 2027. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is pleased to announce the 3rd annual event in the Cell & Gene Therapy Virtual Event Series, taking place on October 13th, 2027. The Cell & Gene Therapy planning committee w...
Labroots is excited to announce the 18th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 10th, 2027! This event will again bring togethe...